SYMPOSIUM IS ORGANISED AND SUPPORTED BY GSK

Monday, May 25| 13:00 – 14:30 | Willem Burger Zaal
Chair: Dr xxx (Bxxx)

13:45–13:55

INTRODUCTION
Dr Volker Vetter, Director Global Medical Affairs, GSK (Belgium)

13:55–14:25

DEBATING RV PREVENTION RELATED CONTROVERSIES
Dr. Susanna Esposito, Director of Pediatric Clinic, Full Professor of Pediatrics at Università degli Studi di Perugia, (Italy)

Dr. Marco Safadi, Pediatric Infectious Diseases Specialist at Sabara Children’s Hospital, Head of Pediatric Department at Santa Casa Medicine School of Sao Paulo, (Brazil)

Dr. Patricia Bruijning-Verhagen, Peditrician & Epidemiologist, Associate Professor of Infectious Diseases Epidemiology & Vaccine Preventable Diseases at University Medical Center Utrecht, (The Netherlands)

Dr. Hanna Nohynek, Chief Physician, Debuty Head Unit Infectious Disease Control & Vaccines at National Institute of Health and Welfare THL Helsinki, (Finland)

14:25–15:05

DEBATING PCV PREVENTION RELATED CONTROVERSIES
All

15:05–15:15

CONCLUSION
Dr Volker Vetter, Director Global Medical Affairs, GSK (Belgium)

SYMPOSIUM IS ORGANISED BY:
Pfizer

Monday, May 25| 14:45 – 16:15 | Willem Burger Zaal
Chair: Pxxxx (Ixxx)

14:00–14:05

WELCOME AND OPENING REMARKS
Paolo Manzoni (Italy)

14:05–14:25

TWENTY YEARS OF PALIVIZUMAB: A STATE-OF-THE-ART REVIEW ABOUT EFFICACY, BENEFITS, GAPS AND UNMET NEEDS
Bernhard Resch (Austria)

14:25–14:45

NEW GENERATION MONOCLONALS AGAINST RSV: GOING BEYOND PALIVIZUMAB
Octavio Ramilo (USA)

14:45–15:10

RESULTS FROM THE PHASE 2B RCT OF MEDI-8897, A NEW MONOCLONAL AGAINST RSV – WILL A NEW APPROACH TO PREVENTION BE POSSIBLE?
Paolo Manzoni (Italy)

15:10–15:30

PLENARY DISCUSSION & CLOSING REMARKS
Paolo Manzoni (Italy)

SYMPOSIUM IS ORGANISED BY Pfizer

Monday, May 25| 16:45 – 18:15| Willem Burger Zaal

Chair: Jxxxxxx (Uxx)

10:40–11:15

TB: STILL A DIAGNOSTIC CHALLENGE?
Dr. Marc Tebruegge, Senior Lecturer at the GOS Institute of Child Health, University College London (UK)

11:15–11:45

POINT OF CARE TESTING FOR FLU/RSV: A UK PILOT STUDY
Dr. John Boyes, Consultant medical microbiology, Gloucestershire hospitals, NHS Foundation Trust (UK)

11:45–12:15

EARLY RAPID DIAGNOSIS IS VITAL IN THE COMING ERA OF ANTIVIRALS AND VACCINES
Prof. Peter JM Openshaw  FRCP PhD FRSB FMedSci, National Heart & Lung Institute, Imperial College London (St. Mary’s Campus) (UK)

SYMPOSIUM IS ORGANISED BY MSD

Monday, May 25| 18:30 – 20:00 | Willem Burger Zaal
Co-Chairs: Prof xxx (Lxxxx) and

18:30–18:35

WELCOME AND INTRODUCTION
Dr Wilhelm Erber, Director Medical and Scientific Affairs, Global Vaccines, Pfizer (Austria) and  Prof Dace Zavadska, Department of Paediatrics, Riga Stradins University (Latvia)

18:35–19:00

TBE: MAPPING THE RISK
Prof Dace Zavadska (Latvia)

19:00–19:25

TBE: A NEGLECTED TOPIC IN CHILDREN
Prof Robert Steffen, Epidemiology, Biostatistics and Prevention Institute, WHO Collaborating Centre for Travellers’ Health, University of Zurich (Switzerland)

19:25–19:50

TBE: AN UPDATED PERSPECTIVE
Dr Gerhard Dobler, Head of the Department of Virology and Rickettsiology at the Institute of Microbiology, Bundeswehr, Munich (Germany)

19:50–20:00

Q&A
Dr Wilhelm Erber (Austria)

SYMPOSIUM IS ORGANISED BY Sanofi

Tuesday, May 26 | 08:30 – 10:00| Grote Zall
Chair: Dr Jxxx (Pxxx)

11:30–11:35

WELCOME AND INTRODUCTION
Dr Jamie Findlow (Pfizer)

11:35–12:00

IS THE UNPREDICTABILITY OF MENINGOCOCCAL DISEASE PREDICTABLE?
Prof Paula Mölling, Molecular biologist, University Hospital Örebro (Sweden)

12:00–12:25

COMBATTING THE HYPERVIRULENT MENW CC11 CLONE: LESSONS LEARNT FROM THE SUCCESSFUL UK IMPLEMENTATION OF MENACWY VACCINE
Dr Shamez Ladhani, Paediatric infectious disease consultant, St. George’s
Hospital (UK)

12:25–12:50

THE ABILITY OF MENB-FHBP TO PROVIDE BROAD MEN B COVERAGE
Dr Laura York, Independent consultant (USA)

12:50–13:00

PANEL DISCUSSION
All

13:00

CLOSE
Dr Jamie Findlow (Pfizer)

SYMPOSIUM IS ORGANISED BY GSK

Tuesday, May 26 | 10:15 – 11:45 | Grote Zaal
Chair: Maxxxx (Sxxx)

16:45–16:50

WELCOME AND INTRODUCTION
Heinz-Josef Schmitt (Pfizer, US)

16:50–17:00

PNEUMOCOCCAL DISEASE IN SLOVENIA
Marko Pokorn (Slovenia)

17:00–18:00

PANEL DISCUSSION – EXAMINING THE EVIDENCE
Heinz-Josef Schmitt (Pfizer, US), Marko Pokorn (Slovenia), Ron Dagan (Israel), Robert Cohen (France), Naim Ouldali (France), Shalom Ben-Shimol (Israel)   

18:00–18:15

Q&A
All

SYMPOSIUM IS ORGANISED BY MSD

Tuesday, May 26| 12:15 – 13:45| Grote Zaal
Chair: Fxxx(Sxx)

14:45–14:50

WELCOME AND INTRODUCTION
Federico Martinon-Torres, Hospital Clínico Universitario de Santiago (Spain)

14:50–15:15

WHERE ARE WE AND WHERE ARE WE GOING WITH
PNEUMOCOCCAL VACCINATION IN CHILDREN?
Richard Malley, Boston Children’s Hospital (USA)

15:15–15:35

HEXAVALENT VACCINATION IN THE YEAR 2019
Johannes Huebner, Klinikum der Ludwig- Maximilians-Universität (Germany)

15:35–16:00

CAN VACCINE MAGIC CONVERT VACCINE SKEPTICS?
Federico Martinon-Torres, Hospital Clínico Universitario de Santiago (Spain)

16:00–16:15

Q&A and Closing Remarks
Federico Martinon-Torres, Hospital Clínico Universitario de Santiago (Spain)

SYMPOSIUM IS ORGANISED BY Pfizer

Tuesday, May 26| 14:30 – 16:00 | Grote Zall
Chair: Axxxx (Uxx)

09:30–09:42

OPENING AND WELCOME MAXIMIZING THE POTENTIAL FOR ELIMINATION OF HPV CANCERS & DISEASES
Anna Giuliano, Dorothea Bennett Memorial –American Cancer Society (ACS)Clinical Research Professor Director, Center for Immunization and Infection Research in Cancer (CIIRC)Moffitt Cancer Center (USA)

09:42–09:54

HPV IN MALES: RATIONAL FOR GENDER NEUTRAL VACCINATION
Anna Giuliano (USA)

09:54–10:06

UNCOVERING THE POTENTIAL FOR HPV VACCINATION IN THE REAL WORLD
Paolo Bonanni, Full Professor of Hygiene and Public Health Department of Health Sciences University of Florence (Italy)

10:06–10:18

VACCINE CONFIDENCE IN TODAY’S WORLD
Pierre Van Damme, Full Professor University of Antwerp Director of the Centre for the Evaluation of Vaccination (CEV) Vice-Dean of the Faculty of Medicine and Health Sciences Antwerp (Belgium)

10:18–10:45

PANEL DISCUSSION
All

10:45–11:00

Q&A SESSION
All